You may also like
Page 8 of 28
In this episode of the Focus on Eye Health Podcast, host Christopher Hord talks with Michael Lehmicke of the Alliance for Regenerative Medicine (ARM). Michael explains how cutting-edge cell and gene therapies are transforming treatment options for conditions like age-related macular degeneration (AMD), retinitis pigmentosa, Stargardt disease, and other vision disorders. Learn about current clinical trials, FDA-approved therapies, and what the future may hold for people living with blindness and low vision.
This episode is sponsored by BlueRock Therapeutics.